Literature DB >> 29475842

Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787.

Jay M Sosenko, Jay S Skyler, Jeffrey Mahon, Jeffrey P Krischer, Craig A Beam, David C Boulware, Carla J Greenbaum, Lisa E Rafkin, Catherine Cowie, David Cuthbertson, Jerry P Palmer.   

Abstract

Entities:  

Year:  2018        PMID: 29475842      PMCID: PMC5860834          DOI: 10.2337/dc18-er04a

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
In the article cited above, the last paragraph of the RESULTS section was corrected to read: The application of the DPTRS is presented in the following hypothetical example. An 8-year-old with a BMI of 18.0 kg/m2 (log = 2.89) has normal glucose tolerance with fasting, 30-, 60-, 90-, and 120-min values of 80 mg/dL, 150 mg/dL, 160 mg/dL, 140 mg/dL, and 120 mg/dL, respectively. Fasting, 30-, 60-, 90-, and 120-min C-peptide values are 0.86 ng/mL (log = -0.151), 2.5 ng/mL, 3.1 ng/mL, 3.2 ng/mL, and 2.8 ng/mL, respectively. Using the DPTRS coefficients and the above information, the DPTRS value equals (1.569 × log BMI) + (−0.056 × age) + (0.813 × glucose sum from 30 to 120 min/100) + (−0.848 × C-peptide sum from 30 to 120 min/10) + (0.476 × log fasting C-peptide) = 7.66. This converts to a 3-year risk estimate of 0.59. The online version (https://doi.org/10.2337/dc11-0641) has been corrected to reflect these changes.
  1 in total

1.  A rule-based prognostic model for type 1 diabetes by identifying and synthesizing baseline profile patterns.

Authors:  Ying Lin; Xiaoning Qian; Jeffrey Krischer; Kendra Vehik; Hye-Seung Lee; Shuai Huang
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.